Target intelligence / Profile preview

RNA, U6 small nuclear 320, pseudogene (RNU6-320P)

Target
RNU6-320P
Molecular classification
Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNU6-320P (RNA, U6 small nuclear 320, pseudogene) is a pseudogene copy related to U6 small nuclear RNA (snRNA), a highly conserved non-coding RNA integral to spliceosome function and pre-mRNA splicing in eukaryotes[5][6]. Pseudogenes like RNU6-320P are genomic DNA sequences similar to known genes but typically non-functional due to mutations or lack of necessary regulatory elements; they do not produce functional RNA or protein products[4][6]. Many U6 snRNA pseudogenes are present in the human genome, generated mainly through retrotransposon-mediated events, and serve as markers of genome dynamics rather than active participants in biological processes[4][5][6]. RNU6-320P itself plays no established therapeutic target role—it does not encode an enzyme, receptor, transporter, or other typical drug target. There are no known small molecules, biologics, or drugs that interact directly with this pseudogene[6]. While U6 snRNA is functionally critical for splicing, RNU6-320P is best classified as a *processed small RNA pseudogene*—it may have residual non-coding functions in rare regulatory contexts, but none are well-documented or therapeutically relevant[4][6].

Other names
RNU6-320PRNA, U6 small nuclear 320, pseudogene
02

Biological functions

Does not perform active cellular functions (serves as a marker of genome dynamics)
03

Disease associations

No known direct disease role; pseudogenes generally do not encode functional products but may occasionally have regulatory or biomarker roles in rare contexts

Beyond the preview

Go deeper on RNA, U6 small nuclear 320, pseudogene (RNU6-320P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 320, pseudogene (RNU6-320P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call